NP / PA
Mother Frances Hospital Jacksonville
Mother Frances Hospital Jacksonville was paid $3.42M by Medicaid between Mar 2020 and Nov 2024, across 52 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.
33Billing provider infoMOTHER FRANCES HOSPITAL JACKSONVILLE
JACKSONVILLE, TX 75766
JACKSONVILLE, TX 75766
33aNPI1952306672assigned 06/17/2005
33bProvider typeCertified Registered Nurse Anesthetist
28Total paid$3.42M
24GClaims50,411
24DCodes billed52
24AFirst – last monthMar 2020 – Nov 2024
Compared with peers
Next to other Certified Registered Nurse Anesthetist providers in Texas
Rank by total paid#5 of 67
Median peer was paid$31K
This provider vs. median109×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,932 | $79K | |
| 2021 | 13,972 | $702K | |
| 2022 | 16,323 | $1.16M | |
| 2023 | 13,288 | $1.09M | |
| 2024incomplete | 4,896 | $389K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 42% | 15,101 | 9,695 | $1.44M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 4,424 | 3,066 | $1.05M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.5% | 3,143 | 2,178 | $223K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.0% | 6,997 | 3,865 | $172K |
| 87428 | 4.5% | 2,812 | 2,752 | $153K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.2% | 175 | 139 | $111K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 698 | 625 | $63K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.1% | 1,547 | 1,142 | $37K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 354 | 334 | $25K |
| 71045 | Radiologic examination, chest; single view | <1% | 676 | 618 | $24K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 624 | 608 | $16K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 193 | 183 | $14K |
40 more codes
| 80053 | Comprehensive metabolic panel | <1% | 1,941 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,645 | $13K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 13 | $9K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,200 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 25 | $8K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 76 | $7K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 939 | $4K |
| 87070 | <1% | 279 | $4K | |
| 94760 | <1% | 61 | $4K | |
| 81001 | <1% | 1,300 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 76 | $2K |
| 84484 | <1% | 387 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 12 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 358 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 32 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 117 | $2K |
| 83880 | <1% | 58 | $1K | |
| 80061 | Lipid panel | <1% | 258 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 116 | $989.86 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 170 | $729.16 |
| 90461 | <1% | 194 | $728.73 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 127 | $411.07 |
| 90686 | <1% | 281 | $349.37 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 108 | $340.98 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 343 | $292.92 |
| 87807 | <1% | 13 | $255.43 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 129 | $78.73 |
| 87186 | <1% | 24 | $50.13 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 13 | $45.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $38.60 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,398 | $17.67 |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | 0% | 236 | $0.00 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 298 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 13 | $0.00 |
| 90662 | 0% | 14 | $0.00 | |
| 82962 | 0% | 335 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 25 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 14 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 13 | $0.00 |
| 90651 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHUFF, ANGELA (PROVIDER ENROLLMENT SPECIALIST)